References
- CENTERS FOR DISEASE CONTROL., Acquired immunodeficiency syndrome associated with intravenous drug use: United States 1989. Morbid. Mortal. Wkly. Rep. 1989; 38: 165–170
- Chaisson R. E., Bachetti P., Osmond D., Brodie B., Sande M. A., Moss A. R. Cocaine use and HIV infection in intravenous drug users in San Francisco. J. Am. Med. Assoc. 1989; 261: 561–565
- Chaisson R. E., Osmond D., Moss A. R., Biernacki P., Feldman H. W. HIV, bleach, and needle sharing (letter). Lancet 1987; 2: 1430
- CONSORTIUM FOR RETROVIRUS SEROLOGY STANDARDIZATION., Serological diagnosis of human immunodeficiency virus infection by Western blot testing. J. Am. Med. Assoc. 1988; 260: 674–679
- Des Jarlais D. C., Friedman S. R. HIV and intravenous drug use. AIDS 1988a; 2: S65–S69, Suppl.
- Des Jarlais D. C., Friedman S. R. Needle sharing among IVDUs at risk for AIDS. Am. J. Public Health 1988b; 78: 1498
- Des Jarlais D. C., Friedman S. R., Hopkins W. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann. Intern. Med. 1985; 103: 755–759
- Des Jarlais D. C., Sothern J., Stoneburner R., et al. HIV-1 is associated with fatal infectious diseases other than AIDS among intravenous drug users (Abstract). IV International Conference on AIDS. Stockholm June, 1988; 1: 314
- Feldman H. W. A neighborhood history of drug switching. Street Ethnography: Selected Studies of Crime and Drug Use in Natural Settings, R. Wepner. Sage Publications, Beverly Hills, California 1977; 249–278
- Feldman H. W., Mandel J., Fields A. In the neighborhood: A strategy for delivering early intervention services to young drug users in their natural environments. Treatment Services for Adolescent Substance Abusers, A. S. Friedman, G. M. Beschner. National Institute on Drug Abuse, Rockville, Maryland 1985; 112–128, Treatment Research Monograph Series., DHHS Pub No. (ADM)85–1342
- Hahn R. A., Onorato I. M., Jones T. S., Dougherty J. Prevalence of HTV infection among intravenous drug users in the United States. J. Am. Med. Assoc. 1989; 291: 2677–2684
- Hartel D., Selwyn P. A., Schoenbaum E. E., Klein R. S., Friedland G. H. Methadone maintenance treatment (MMTP) and reduced risk of AIDS and AIDS-spe-cific mortality in intravenous drug users (IVDUs) (Abstract). IV International Conference on AIDS. Stockholm June, 1988; 2: 295
- Jaffe J. H. Drug addiction and drug abuse. Vie Pharmacological Basis of Therapeutics, L. S. Goodman, A. Gilman. Macmillan, New York 1975; 245–283
- Lampinan T., Weibel W. W., Waiters J. K. Letter. J. Am. Med Assoc. 1989; 262: 1331
- Lewis D. K., Waiters J. K. Seropositivity and IVDUs: Ethnic/gender comparisons (letter). Am. J. Public Health 1988; 78: 1499
- OFFICE OF TECHNOLOGY ASSESSMENTCONGRESS OF THE UNITED STATES. How Effective Is AIDS Education? June, 1988; 4, GPO stock no. 052–003–01120
- Romesburg H. C. Cluster Analysis for Researchers. Lifetime Learning Publications, Belmont, California 1984
- SAS SUPPLEMENTAL USERS GUIDEEdition. SAS Institute, Cary, North Carolina 1980
- Waiters J. K., Biernacki P. Targeted sampling with hidden populations: An emerging research methodology. Soc. Probl. 1989; 36: 416–430
- Waiters J. K., Case P., Huang K. H. C, Cheng Y-T., Lorvick J. J., Carlson J. R. HIV seroepidemiology and behavior change in intravenous drug users: Progress report on the effectiveness of street-based prevention (Abstract). IV International Conference on AIDS. Stockholm June, 1988; 2: 389
- Weibel W. W. Testimony before the United States House of Representatives, Subcommittee on Health and Environment. Update on the AIDS epidemic: Epidemiology, basic, and clinical research, and health care. Washington, D.C. April 4, 1988